Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Share-based Compensation (2017 - 2026)

Arvinas (ARVN) posted quarterly Share-based Compensation of $12.1 million for Q1 2026, down 19.33% year-over-year from $15.0 million in Q1 2025, and up 42.35% quarter-over-quarter from $8.5 million in Q4 2025.

Analysis

Arvinas (ARVN) Share-based Compensation (2017 - 2026) Analysis & Trends

Arvinas' Share-based Compensation history runs 10 years deep, the most recent figure standing at $12.1 million for Q1 2026.

  • In Q1 2026, Share-based Compensation fell 19.33% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $41.1 million (down 51.42% YoY), while the FY2025 annual figure was $44.0 million, down 50.11% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $12.1 million, up from $8.5 million in the prior quarter.
  • The five-year high for Share-based Compensation was $24.7 million in Q3 2024, with the low at $8.5 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $18.3 million (2023), against an average of $17.1 million.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation surged 61.17% in 2022, then plunged 63.52% in 2025.
  • Arvinas' Share-based Compensation stood at $20.1 million in 2022, then declined by 16.92% to $16.7 million in 2023, then surged by 39.52% to $23.3 million in 2024, then plunged by 63.52% to $8.5 million in 2025, then surged by 42.35% to $12.1 million in 2026.
  • Business Quant data shows ARVN's Share-based Compensation at $12.1 million in Q1 2026, $8.5 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Arvinas 609.77 Mn 41.87 Mn - 5.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.90 Mn
Mar 31, 2026 12.10 Mn
Dec 31, 2025 8.50 Mn
Sep 30, 2025 10.20 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 24.70 Mn
Jun 30, 2024 21.60 Mn
Mar 31, 2024 18.60 Mn
Dec 31, 2023 16.70 Mn
Sep 30, 2023 16.70 Mn
Jun 30, 2023 18.30 Mn
Mar 31, 2023 19.90 Mn
Dec 31, 2022 20.10 Mn
Sep 30, 2022 18.80 Mn
Jun 30, 2022 20.00 Mn
Mar 31, 2022 16.60 Mn
Dec 31, 2021 17.00 Mn
Sep 30, 2021 15.22 Mn